Clinical Staging of Prostaglandin-Associated Periorbitopathy Syndrome in Glaucoma: A Review from Asia

REFERENCES

• Sakata R, Chang PY, Sung KR, et al. Prostaglandin-associated periorbitopathy syndrome (PAPS): addressing an unmet clinical need. Semin Ophthalmol. 2022;37(4):447–454. doi:10.1080/08820538.2021.2003824.
   PubMed Web of Science ®Google Scholar
• Taketani Y, Yamagishi R, Fujishiro T, et al. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1269–1276. doi:10.1167/iovs.13-12589.
   PubMed Web of Science ®Google Scholar
• Inoue K, Shiokawa M, Wakakura M, et al. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs. J Glaucoma. 2013;22(8):626–631. doi:10.1097/IJG.0b013e31824d8d7c.
   PubMed Web of Science ®Google Scholar
• Kucukevcilioglu M, Bayer A, Uysal Y, et al. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clin Exp Ophthalmol. 2014;42(2):126–131. doi:10.1111/ceo.12163.
   PubMed Web of Science ®Google Scholar
• Matsuo M, Matsuoka Y, Tanito M. Efficacy and patient tolerability of omidenepag isopropyl in the treatment of glaucoma and ocular hypertension. Clin Ophthalmol. 2022;16:1261–1279. doi:10.2147/OPTH.S340386.
   PubMed Web of Science ®Google Scholar
• Patradul C, Tantisevi V, Manassakorn A. Factors related to prostaglandin-associated periorbitopathy in glaucoma patients. Asia Pac J Ophthalmol (Phila). 2017;6(3):238–242. doi:10.22608/APO.2016108.
   PubMedGoogle Scholar
• Sarnoff DS, Gotkin RH. Bimatoprost-induced chemical blepharoplasty. J Drugs Dermatol. 2015;14(5):472–477.
   PubMed Web of Science ®Google Scholar
• Shah M, Lee G, Lefebvre DR, et al. A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features. PLOS ONE. 2013;8(5):e61638. doi:10.1371/journal.pone.0061638.
   PubMed Web of Science ®Google Scholar
• Kim HW, Choi YJ, Lee KW, et al. Periorbital changes associated with prostaglandin analogs in Korean patients. BMC Ophthalmol. 2017;17(1):126. doi:10.1186/s12886-017-0521-4.
   PubMed Web of Science ®Google Scholar
• Manju M, Pauly M. Prostaglandin-associated periorbitopathy: A prospective study in Indian eyes. Kerala J Oph. 2020;32(1):36–40. doi:10.4103/kjo.kjo_90_19.
   Google Scholar
• Aihara M, Shirato S, Sakata R. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost. Jpn J Ophthalmol. 2011;55(6):600–604. doi:10.1007/s10384-011-0075-6.
   PubMed Web of Science ®Google Scholar
• Tanito M, Ishida A, Ichioka S, et al. Proposal of a simple grading system integrating cosmetic and tonometric aspects of prostaglandin-associated periorbitopathy. Medicine. 2021;100(34):e26874. doi:10.1097/MD.0000000000026874.
   PubMed Web of Science ®Google Scholar
• Davis SA, Sleath B, Carpenter DM, et al. Drop instillation and glaucoma. Curr Opin Ophthalmol. 2018;29(2):171–177. doi:10.1097/ICU.0000000000000451.
   PubMed Web of Science ®Google Scholar
• Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol. 2014;8:903–913. doi:10.2147/OPTH.S44708.
   PubMedGoogle Scholar
• Tan J, Berke S. Latanoprost-induced prostaglandin-associated periorbitopathy. Optom Vis Sci. 2013;90(9):e245–e247. doi:10.1097/OPX.0b013e31829d8dd7.
   PubMed Web of Science ®Google Scholar
• Sano I, Takahashi H, Inoda S, et al. Shortening of interpupillary distance after instillation of topical prostaglandin analog eye drops. Am J Ophthalmol. 2019;206:11–16. doi:10.1016/j.ajo.2019.03.013.
   PubMed Web of Science ®Google Scholar
• Lee GA, Ritch R, Liang SY, et al. Tight orbit syndrome: a previously unrecognized cause of open-angle glaucoma. Acta Ophthalmol. 2010;88(1):120–124. doi:10.1111/j.1755-3768.2009.01755.x.
   PubMed Web of Science ®Google Scholar
• Lee YK, Lee JY, Moon JI, et al. Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome. Jpn J Ophthalmol. 2014;58(6):496–502. doi:10.1007/s10384-014-0343-3.
   PubMed Web of Science ®Google Scholar
• Miki T, Naito T, Fujiwara M, et al. Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy. PLOS ONE. 2017;12(7):e0181550. doi:10.1371/journal.pone.0181550.
   PubMed Web of Science ®Google Scholar
• Pasquale LR. Therapeutics update prostaglandin-associated periorbitopathy a postmarketing surveillance observation. Glaucoma Today. 2011;Early Summer 2011:51–58.
   Google Scholar
• Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013.
   PubMed Web of Science ®Google Scholar
• Nouveau S, Agrawal D, Kohli M, et al. Skin hyperpigmentation in Indian population: insights and best practice. Indian J Dermatol. 2016;61(5):487–495. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029232/.
   PubMed Web of Science ®Google Scholar
• Hickson-Curran S, Brennan NA, Igarashi Y, et al. Comparative evaluation of Asian and White ocular topography. Optom Vis Sci. 2014;91(12):1396–1405. doi:10.1097/OPX.0000000000000413.
   PubMed Web of Science ®Google Scholar
• Kiranantawat K, Suhk JH, Nguyen AH. The Asian eyelid: relevant anatomy. Semin Plast Surg. 2015;29(3):158–164. doi:10.1055/s-0035-1556852.
   PubMed Web of Science ®Google Scholar
• Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134–149. doi:10.1016/j.preteyeres.2017.09.004.
   PubMed Web of Science ®Google Scholar
• Ha A, Kim CY, Shim SR, et al. Degree of myopia and glaucoma risk: a dose-response meta-analysis. Am J Ophthalmol. 2022;236:107–119. doi:10.1016/j.ajo.2021.10.007.
   PubMed Web of Science ®Google Scholar
• Haarman AEG, Enthoven CA, Tideman JWL, et al. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. doi:10.1167/iovs.61.4.49.
   PubMed Web of Science ®Google Scholar
• Rabinowitz MP, Katz LJ, Moster MR, et al. Unilateral prostaglandin-associated periorbitopathy: a syndrome involving upper eyelid retraction distinguishable from the aging sunken eyelid. Ophthalmic Plast Reconstr Surg. 2015;31(5):373–378. doi:10.1097/IOP.0000000000000351.
   PubMed Web of Science ®Google Scholar
• Ishida A, Miki T, Naito T, et al. Surgical results of trabeculectomy among groups stratified by prostaglandin-associated periorbitopathy severity. Ophthalmology. 2023;130(3):297–303. doi:10.1016/j.ophtha.2022.10.024.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Lower lid distraction test. American Academy of Ophthalmology, 2024. https://www.aao.org/education/image/lower-lid-distraction-test.
   Google Scholar
• American Academy of Ophthalmology. Snap back test. American Academy of Ophthalmology, 2024. https://www.aao.org/education/image/snap-back-test.
   Google Scholar
• Labib A, Patel BC, Milroy C. Lower eyelid laxity examination. StatPearls. Treasure Island, FL: StatPearls Publishing Copyright 2023, StatPearls Publishing LLC; 2023.
   Google Scholar
• Esporcatte BL, Lopes FS, Fonseca Netto C, et al. Rebound tonometry versus Goldmann tonometry in school children: feasibility and agreement of intraocular pressure measurements. Arq Bras Oftalmol. 2015;78(6):359–362. doi:10.5935/0004-2749.20150095.
   PubMed Web of Science ®Google Scholar
• Smedowski A, Weglarz B, Tarnawska D, et al. Comparison of three intraocular pressure measurement methods including biomechanical properties of the cornea. Invest Ophthalmol Vis Sci. 2014;55(2):666–673. doi:10.1167/iovs.13-13172.
   PubMed Web of Science ®Google Scholar
• Termühlen J, Mihailovic N, Alnawaiseh M, et al. Accuracy of measurements with the iCare HOME rebound tonometer. J Glaucoma. 2016;25(6):533–538. doi:10.1097/IJG.0000000000000390.
   PubMed Web of Science ®Google Scholar
• Adewara BA, Singh S. Ocular adnexal changes after antiglaucoma medication use. Int Ophthalmol Clin. 2023;63(3):47–58. doi:10.1097/IIO.0000000000000456.
   PubMedGoogle Scholar
• Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 2021;11(4):116–129. doi:10.5662/wjm.v11.i4.116.
   PubMedGoogle Scholar